DCF — SANFORD USD MEDICAL CENTER
Enterprise Value: $-862.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-862.5M
Enterprise Value
$-296.8M
PV of Cash Flows
$-565.7M
PV of Terminal Value
$-911.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.3B | $-40.7M | -3.0% | $-93.6M | $-85.1M |
| Year 2 | $1.3B | $-29.0M | -2.0% | $-83.6M | $-69.0M |
| Year 3 | $1.3B | $-16.6M | -1.0% | $-72.8M | $-54.7M |
| Year 4 | $1.4B | $-10.3M | -1.0% | $-68.1M | $-46.5M |
| Year 5 | $1.4B | $-7.1M | -1.0% | $-66.7M | $-41.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-862.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.2B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03753941072831486
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5